At Davis's insistence, the editorial board decided to conduct a joint review of Li Xu's paper.
The review began. They meticulously examined every aspect of the paper, including its research methodology, data analysis, and the derivation of its conclusions.
Thomas, though burning with anxiety, was powerless to stop it.
The minutes ticked by in the silent conference room.
When all the editors had finished their review, Davis spoke again. "Well, everyone, what are your thoughts on this paper?"
A senior editorial consultant was the first to speak. "Mr. Davis, I've read this paper thoroughly. Its research design is rigorous, the data is comprehensive, and the explanation of the molecular mechanism of action is particularly clear. The results of the clinical double-blind controlled trial are also highly persuasive. Personally, I believe this paper fully meets the publication standards of *Lancet*."
